Skip to content
DefDex

Federal award

DIAGNOSTICA STAGO INC

W81K0221P0156

Contract

Obligated and Ceiling

Obligated (net)
$490,270.41
Ceiling (potential value, not spending)
$490,270.41
Current value
$490,270.41
Gross positive obligations
$510,129.45

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
DIAGNOSTICA STAGO INC · ND7MY2A4ZUE9
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
DIAGNOSTICA STAGO INC · ND7MY2A4ZUE9
Awarding agency
Department of War · sub-agency 2100 · office W81K02
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0221P0156
Award type code
B
Actions
13 · Sep 9, 2021 to Oct 30, 2024
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History13

Award actions
DateFYModAction typeObligationCompany in company totals
Oct 30, 2024FY2025P00012C$131,651.24
—
Jun 26, 2024FY2024P00011G$0.00
—
Mar 27, 2024FY2024P00010M$0.00
—
Feb 1, 2024FY2024P00009B−$19,859.04
—
Nov 20, 2023FY2024P00008B$75,175.73
—
Aug 10, 2023FY2023P00007G$0.00
—
Jul 12, 2023FY2023P00006B$0.00
—
May 10, 2023FY2023P00005M$0.00
—
Nov 9, 2022FY2023P00004C$131,651.24
—
Aug 11, 2022FY2022P00003G$0.00
—
Mar 21, 2022FY2022P00002B$40,000.00
—
Nov 8, 2021FY2022P00001C$131,651.24
—
Sep 9, 2021FY20210—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.